Drug Shortage Report for ACH-QUETIAPINE FUMARATE XR
Report ID | 213623 |
Drug Identification Number | 02450860 |
Brand name | ACH-QUETIAPINE FUMARATE XR |
Common or Proper name | QUETIAPINE FUMARATE |
Company Name | ACCORD HEALTHCARE INC |
Market Status | MARKETED |
Active Ingredient(s) | QUETIAPINE |
Strength(s) | 50MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 60 |
ATC code | N05AH |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-12-15 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-01-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2024-01-19 | French | Compare |
v4 | 2024-01-19 | English | Compare |
v3 | 2023-12-15 | French | Compare |
v2 | 2023-12-15 | French | Compare |
v1 | 2023-12-15 | English | Compare |
Showing 1 to 5 of 5